Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

VIVUS Inc (NASDAQ:VVUS)

1.08
Delayed Data
As of 3:59pm ET
 -0.02 / -1.82%
Today’s Change
0.92
Today|||52-Week Range
2.25
+5.88%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$114.5M

Company Description

VIVUS, Inc. operates as a biopharmaceutical company, which develops innovative, next-generation therapies to address unmet needs in obesity, diabetes, sleep apnea and sexual health. The company's products include Qsymia Obesity, Qsymia Sleep Apnea, Qsymia Diabetes and Avanafil. VIVUS was founded by Virgil A. Place on April 16, 1991 and is headquartered in Mountain View, CA.

Contact Information

VIVUS, Inc.
351 East Evelyn Avenue
Mountain View California 94041
P:(650) 934-5200
Investor Relations:

Employees

Shareholders

Mutual fund holders6.45%
Other institutional37.81%
Individual stakeholders27.11%

Top Executives

Seth H. Z. FischerChief Executive Officer & Director
Mark K. OkiChief Financial & Accounting Officer
Santosh T. VargheseChief Medical Officer
Johann Noor MohamedVice President & Controller
Sandra E. WellsVice President-Patents & Assistant General Counsel